Metabolomic profiling for drug-induced liver injury with autoantibodies
Yan-Zhong Han,Zhi-Tao Ma,Ming-Xi Zhou,Ming Niu,Xu Zhao,Yu-Ming Guo,Xin-Hua Song,Ya-Wen Lu,Zhao-Fang Bai,Zhen Li,Han Gao,Yong-Kang Zhao,Jia-Bo Wang,Xiao-He Xiao,Jing Jing,Yan-zhong Han,Zhi-tao Ma,Ming-xi Zhou,Yu-ming Guo,Xin-hua Song,Ya-wen Lu,Zhao-fang Bai,Yong-kang Zhao,Jia-bo Wang,Xiao-he Xiao
DOI: https://doi.org/10.1016/j.intimp.2022.109084
IF: 5.714
2022-08-05
International Immunopharmacology
Abstract:Backgrounds Drug induced liver injury (DILI) is sometimes similar to autoimmune hepatitis (AIH) in serology and histology. Clinicians empirically screened DILI with significant autoimmune characteristics to implement clinical intervention. We tried to characterize DILI with autoantibodies by metabolomics. Methods Untargeted metabolomics coupled with pattern recognition approaches were performed on sera samples including AIH (n = 59), DILI with autoantibodies (DILI Ab+ , n = 68), and DILI without autoantibodies (DILI Ab- , n = 75). The differential metabolites and fingerprint metabolites between AIH and DILI Ab- were screened by orthogonal partial least squares-discriminant analysis and hierarchical clustering respectively. Results Of the 388 annotated differential metabolites between AIH and DILI Ab- , 74 fingerprint metabolites were screened. The eigenmetabolite compressed from the fingerprint possessed high discrimination efficacy (AUC:0.891; 95 %CI, 0.838–0.944). In the fingerprint-based PCA model, AIH and DILI Ab- were separated into three regions: the "pure region" of AIH (Region 1), the "pure region" of DILI Ab- (Region 3), the mixture region of AIH and DILI Ab- (Region 2). After incorporated into the PCA model, DILI Ab+ samples were distributed into the three regions, indicating that DILI Ab+ samples had different etiological tendencies. Moreover, the fingerprint-based radar model verified the results of PCA model characterizing DILI Ab+ . Notably, the antibody titers of DILI Ab+ in the three regions did not differ significantly, while the response rates for glucocorticoids were obviously different. The metabolic difference among DILI Ab+ in different regions mainly lies in energy metabolism. Conclusions In terms of metabolic signature, DILI Ab+ may not be a community of same pathogenesis, including AIH-inclined parts. Which deserves further study.
pharmacology & pharmacy,immunology